Top

Obesity Surgery

Published in:

01-08-2008 | Review

Nutritional Deficiencies in Morbidly Obese Patients: A New Form of Malnutrition?

Part B: Minerals

Authors: Orit Kaidar-Person, Benjamin Person, Samuel Szomstein, Raul J. Rosenthal

Published in: Obesity Surgery | Issue 8/2008

Abstract

Even though in the Western world there is almost no limitation to a wide variety of food supply, nutritional deficiencies can be found in both normal-weight population and in the obese population. In this review, we examine the prevalence and manifestations of various mineral deficiencies in obese patients.

Gibson RS. The role of diet- and host-related factors in nutrient bioavailability and thus in nutrient-based dietary requirement estimates. Food Nutr Bull. 2007;28(1):S77–100.PubMed

Bringhurst RF, Demay MB, Krane SM, Kronenberg HM. Bone and mineral metabolisim in health and disease. In: Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL, editors. Harrison’s principles of internal medicine. Vol 2. 16th ed. McGraw-Hill: Medical Publishing Devision; 2005. p. 2244–6.

Reams SM. Patient education; foods high in magnesium. J Renal Nutr. 2002;12(1):60–4.CrossRef

Kiss SA, Forster T, Dongo A. Absorption and effect of the magnesium content of a mineral water in the human body. J Am Coll Nutr. 2004;23(6):758S–62S.PubMed

Kishore B, Thurlow V, Kessel B. Hypokalaemic rhabdomyolysis. Ann Clin Biochem. 2007;44(Pt 3):308–11.PubMedCrossRef

Beckett AG, Lewis JG. Serum magnesium in diabetes mellitus. Clin Sci. 1959;18:597–604.PubMed

Kekwick A, Pawan GL, Chalmers TM. Resistance to ketosis in obese subjects. Lancet. 1959;2:1157–9.PubMedCrossRef

Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension. 1993;21(6 Pt 2):1024–9.PubMed

Rayssiguier Y, Gueux E, Nowacki W, Rock E, Mazur A. High fructose consumption combined with low dietary magnesium intake may increase the incidence of the metabolic syndrome by inducing inflammation. Magnes Res. 2006;19(4):237–43.PubMed

10.

Sontia B, Touyz RM. Role of magnesium in hypertension. Arch Biochem Biophys. 2007;458(1):33–9.PubMedCrossRef

11.

Barbagallo M, Dominguez LJ. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys. 2007;458(1):40–7.PubMedCrossRef

12.

Sales CH, Pedrosa Lde F. Magnesium and diabetes mellitus: their relation. Clin Nutr. 2006;25(4):554–62.PubMedCrossRef

13.

Huerta MG, Roemmich JN, Kington ML, Bovbjerg VE, Weltman AL, Holmes VF, et al. Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care. 2005;28(5):1175–81.PubMedCrossRef

14.

Walti MK, Zimmermann MB, Spinas GA, Jacob S, Hurrell RF. Dietary magnesium intake in type 2 diabetes. Eur J Clin Nutr. 2002;56(5):409–14.PubMedCrossRef

15.

Sheehan JP. Magnesium deficiency and diabetes mellitus. Magnes Trace Elem. 1991–1992;10(2–4):215–9.

16.

Gillis L, Gillis A. Nutrient inadequacy in obese and non-obese youth. Can J Diet Pract Res. 2005;66(4):237–42.PubMedCrossRef

17.

Thomson CD. Assessment of requirements for selenium and adequacy of selenium status: a review. Eur J Clin Nutr. 2004;58:391–402.PubMedCrossRef

18.

Arthur JR. The role of selenium in thyroid hormone metabolism. Can J Physiol Pharm. 1991;69:1648–52.

19.

Levander OA. Nutrition and newly emerging viral diseases: an overview. J Nutr. 1997;127:948S–50S.PubMed

20.

Longnecker MP, Taylor PR, Levander OA, Howe M, Veillon C, McAdam PA, et al. Selenium in diet, blood, and toenails in relation to human health in a seleniferous area. Am J Clin Nutr. 1991;53:1288–94.PubMed

21.

Madan AK, Orth WS, Tichansky DS, Ternovits CA. Vitamin and trace mineral levels after laparoscopic gastric bypass. Obes Surg. 2006;16(5):603–6.PubMedCrossRef

22.

Kimmons JE, Blanck HM, Tohill BC, Zhang J, Khan LK. Associations between body mass index and the prevalence of low micronutrient levels among US adults. MedGenMed. 2006;8(4):59.PubMed

23.

Ford ES, Smith SJ, Stroup DF, Steinberg KK, Mueller PW, Thacker SB. Homocysteine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int J Epidemiol. 2002;31:59–70.PubMedCrossRef

24.

Gonzalez S, Huerta JM, Alvarez-Uria J, Fernandez S, Patterson AM, Lasheras C. Serum selenium is associated with plasma homocysteine concentrations in elderly humans. J Nutr. 2004;134:1736–40.PubMed

25.

Jacobs ET, Jiang R, Alberts DS, et al. Selenium and colorectal adenoma: results of a pooled analysis. J Natl Cancer Inst. 2004;96:1669–75.PubMedCrossRef

26.

Combs GF Jr. Status of selenium in prostate cancer prevention. Br J Cancer. 2004;91:195–9.PubMed

27.

Goldhaber SB. Trace element risk assessment: essentiality vs. toxicity. Regul Toxicol Pharmacol. 2003;38:232–42.PubMedCrossRef

28.

Miret S, Simpson RJ, McKie AT. Physiology and molecular biology of dietary iron absorption. Annu Rev Nutr. 2003;23:283–301.PubMedCrossRef

29.

Killip S, Bennett JM, Chambers MD. Iron deficiency anemia. Am Fam Phys. 2007;75(5):671–8.

30.

Pinhas-Hamiel O, Newfield RS, Koren I, Agmon A, Lilos P, Phillip M. Greater prevalence of iron deficiency in overweight and obese children and adolescents. Int J Obes Relat Metab Disord. 2003;27(3):416–8.PubMedCrossRef

31.

Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M. Overweight children and adolescents: a risk group for iron deficiency. Pediatrics. 2004;114(1):104–8.PubMedCrossRef

32.

Flancbaum L, Belsley S, Drake V, Colarusso T, Tayler E. Preoperative nutritional status of patients undergoing Roux-en-Y gastric bypass for morbid obesity. J Gastrointest Surg. 2006;10(7):1033–7.PubMedCrossRef

33.

Pittler MH, Ernst E. Dietary supplements for body-weight reduction: a systematic review. Am J Clin Nutr. 2004;79(4):529–36.PubMed

34.

Vincent JB. The potential value and toxicity of chromium picolinate as a nutritional supplement, weight loss agent and muscle development agent. Sports Med. 2003;33(3):213–30.PubMedCrossRef

35.

Wani S, Weskamp C, Marple J, Spry L. Acute tubular necrosis associated with chromium picolinate-containing dietary supplement. Ann Pharmacother. 2006;40(3):563–6.PubMedCrossRef

36.

Ravina A, Slezak L, Mirsky N, Bryden NA, Anderson RA. Reversal of corticosteroid-induced diabetes mellitus with supplemental chromium. Diabet Med. 1999;16(2):164–7.PubMedCrossRef

37.

Anderson RA. Chromium, glucose tolerance, and diabetes. Biol Trace Elem Res. 1992;32:19–24.PubMedCrossRef

38.

Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr. 1977;30(4):531–8.PubMed

39.

Rukgauer M, Zeyfang A. Chromium determinations in blood cells: clinical relevance demonstrated in patients with diabetes mellitus type 2. Biol Trace Elem Res. 2002;86(3):193–202.PubMedCrossRef

40.

Speetjens JK, Collins RA, Vincent JB, Woski SA. The nutritional supplement chromium(III) tris(picolinate) cleaves DNA. Chem Res Toxicol. 1999;12(6):483–7.PubMedCrossRef

41.

Stearns DM. Is chromium a trace essential metal? Biofactors. 2000;11(3):149–62.PubMed

42.

Althuis MD, Jordan NE, Ludington EA, Wittes JT. Glucose and insulin responses to dietary chromium supplements: a meta-analysis. Am J Clin Nutr. 2002;76(1):148–55.PubMed

43.

Vincent JB. The bioinorganic chemistry of chromium(III). Polyhedron. 2001;20(1–2):1–26.CrossRef

44.

Diaz ML, Watkins BA, Li Y, Anderson RA, Campbell WW. Chromium picolinate and conjugated linoleic acid do not synergistically influence diet- and exercise-induced changes in body composition and health indexes in overweight women. J Nutr Biochem. 2008;19(1):61–8.

45.

Volpe SL, Huang HW, Larpadisorn K, Lesser II. Effect of chromium supplementation and exercise on body composition, resting metabolic rate and selected biochemical parameters in moderately obese women following an exercise program. J Am Coll Nutr. 2001;20(4):293–306.PubMed

46.

Sandstead HH. Zinc nutrition in the United States. Am J Clin Nutr. 1973;26(11):1251–60.PubMed

47.

Sandstead HH. Zinc as an unrecognized limiting nutrient. Am J Clin Nutr. 1973;26(8):790–1.PubMed

48.

Jeejeebhoy KN. Human zinc deficiency. Nutr Clin Pract. 2007; 22(1):65–7.PubMedCrossRef

49.

Myung SJ, Yang SK, Jung HY, Jung SA, Kang GH, Ha HK, et al. Zinc deficiency manifested by dermatitis and visual dysfunction in a patient with Crohn’s disease. J Gastroenterol. 1998;33(6):876–9.PubMedCrossRef

50.

Boosalis MG, Solem LD, Cerra FB, Konstantinides F, Ahrenholz DH, McCall JT, et al. Increased urinary zinc excretion after thermal injury. J Lab Clin Med. 1991;118(6):538–45.PubMed

51.

Fawaz F. Zinc deficiency in surgical patients: a clinical study. JPEN J Parenter Enteral Nutr. 1985;9(3):364–9.PubMedCrossRef

52.

USDA National Nutrient Database for Standard Reference: http://www.ars.usda.gov/Services/docs.htm?docid=9673. Last accessed: July 6, 2007.

53.

Sandstrom B. Bioavailability of zinc. Eur J Clin Nutr. 1997;51 Suppl 1:S17–9.PubMed

54.

Wise A. Phytate and zinc bioavailability. Int J Food Sci Nutr. 1995;46:53–63.PubMedCrossRef

55.

Krasovec M, Frenk E. Acrodermatitis enteropathica secondary to Crohn’s disease. Dermatology. 1996;193:361–3.PubMedCrossRef

56.

Smidt K, Pedersen SB, Brock B, Schmitz O, Fisker S, Bendix J, et al. Zinc-transporter genes in human visceral and subcutaneous adipocytes: lean versus obese. Mol Cell Endocrinol. 2007;264(1–2):68–73.PubMedCrossRef

57.

Beletate V, El Dib RP, Atallah AN. Zinc supplementation for the prevention of type 2 diabetes mellitus. Cochrane Database Syst Rev. 2007;24(1):CD005525.

58.

Adachi Y, Yoshida J, Kodera Y, Kiss T, Jakusch T, Enyedy EA, et al. Oral administration of a zinc complex improves type 2 diabetes and metabolic syndromes. Biochem Biophys Res Commun. 2006;351(1):165–70.PubMedCrossRef

59.

Marreiro Ddo N, Geloneze B, Tambascia MA, Lerario AC, Halpern A, Cozzolino SM. Effect of zinc supplementation on serum leptin levels and insulin resistance of obese women. Biol Trace Elem Res. 2006;112(2):109–18.CrossRef

60.

Tubek S. Urinary zinc excretion is normalized in primary arterial hypertension after perindopril treatment. Biol Trace Elem Res. 2006;114(1–3):127–33.PubMedCrossRef

61.

Tubek S. Increased absorption of zinc from alimentary tract in primary arterial hypertension. Biol Trace Elem Res. 2001;83(1):31–8.PubMedCrossRef

62.

Ishikawa Y, Kudo H, Kagawa Y, Sakamoto S. Increased plasma levels of zinc in obese adult females on a weight-loss program based on a hypocaloric balanced diet. In Vivo. 2005;19(6):1035–7.PubMed

63.

Di Martino G, Matera MG, De Martino B, Vacca C, Di Martino S, Rossi F. Relationship between zinc and obesity. J Med. 1993; 24(2–3):177–83.PubMed

64.

Marreiro Ddo N, Fisberg M, Cozzolino SM. Zinc nutritional status and its relationships with hyperinsulinemia in obese children and adolescents. Biol Trace Elem Res. 2004;100(2):137–49.CrossRef

65.

Marreiro Ddo N, Fisberg M, Cozzolino SM. Zinc nutritional status in obese children and adolescents. Biol Trace Elem Res. 2002;86(2):107–22.CrossRef

66.

Chen MD, Lin PY, Sheu WH. Zinc status in plasma of obese individuals during glucose administration. Biol Trace Elem Res. 1997;60(1–2):123–9.PubMedCrossRef

67.

Chen MD, Lin PY, Lin WH, Cheng V. Zinc in hair and serum of obese individuals in Taiwan. Am J Clin Nutr. 1988;48(5):1307–9.PubMed

68.

69.

Johnson FK, Johnson RA, Durante W, Jackson KE, Stevenson BK, Peyton KJ. Metabolic syndrome increases endogenous carbon monoxide production to promote hypertension and endothelial dysfunction in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol. 2006;290(3):R601–8.PubMed

Title: Nutritional Deficiencies in Morbidly Obese Patients: A New Form of Malnutrition?
Part B: Minerals
Authors: Orit Kaidar-Person
Benjamin Person
Samuel Szomstein
Raul J. Rosenthal
Publication date: 01-08-2008
Publisher: Springer-Verlag
Published in: Obesity Surgery / Issue 8/2008
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-007-9350-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Nutritional Deficiencies in Morbidly Obese Patients: A New Form of Malnutrition?

Part B: Minerals

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2008

Lap-Band Causing Left Gastric Artery Erosion Presenting with Torrential Hemorrhage

Serum S100B but not NSE Levels are Increased in Morbidly Obese Individuals Affected by Obstructive Sleep Apnea–Hypopnea Syndrome

Severe Recurrent Hypoglycemia after Gastric Bypass Surgery

Continuous Hemodynamic Monitoring During Laparoscopic Gastric Bypass in Superobese Patients by Pressure Recording Analytical Method

Intragastric Balloon or Diet Alone? A Retrospective Evaluation

Pressure Pulse Contour-derived Stroke Volume and Cardiac Output in the Morbidly Obese Patient